
Goldman Sachs ActiveBeta International Equity ETF (GSIE) Price & Chart
GSIE ETF Chart & Stats
- Day’s Range
- $45.98 - $47.11
- 52-Week Range
- $40.05 - $48.49
- Previous Close
- $47.32
- Volume
- 1.30M
- Average Volume (3M)
- 403.58K
- AUM
- 5.93B
- NAV
- 46.77
- Expense Ratio
- 0.25%
- Holdings Count
- 632
- Beta
- 0.69
- Inception Date
- Nov 06, 2015
- Last Dividend Ex-Date
- Sep 24, 2026
- Dividend Yield
- (2.63%)
- Shares Outstanding
- 128,800,000
- Standard Deviation
- N/A
ETF Overview
Goldman Sachs ActiveBeta International Equity ETF
The Goldman Sachs ActiveBeta International Equity ETF (GSIE) is a sophisticated investment vehicle designed to capture the essence of global equity markets, excluding the U.S., through a dynamic and strategic approach. As a Size and Style-focused ETF, GSIE targets the Total Market, offering investors a comprehensive exposure that spans across various market capitalizations and investment styles. This broad-based niche ETF is meticulously crafted to harness the potential of international markets by employing an ActiveBeta strategy, which seeks to outperform traditional market-cap-weighted indices through advanced factor-based investing. GSIE deploys a multi-factor investment strategy, emphasizing value, momentum, quality, and low volatility, to identify stocks that are poised for long-term growth and stability. By incorporating these factors, the ETF aims to provide a balanced exposure that mitigates risks while capturing upside potential in diverse market conditions. This makes GSIE an appealing choice for investors who are looking to diversify their portfolios with international equities and benefit from the expertise of Goldman Sachs in navigating global market complexities. Furthermore, the ETF's design allows it to adapt to changing market dynamics, offering a more responsive and agile investment option compared to traditional passive index funds. With its focus on a broad market segment and an innovative investment approach, the Goldman Sachs ActiveBeta International Equity ETF stands out as a versatile and intelligent choice for investors seeking to capitalize on international opportunities while maintaining a disciplined and factor-driven investment philosophy.
- Asset Class
- Equity
- Region
- Developed Markets
- Issuer
- Goldman Sachs
- Index Tracked
- Stuttgart Goldman Sachs ActiveBeta Intl.Equity (USD)
- Ticker Symbol
- GSIE
GSIE ETF News


AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s official study title is Breast Cancer Real-World Insights and Decision Guidance Evaluation (BRIDGE-HK) An Observational, Retrospective,

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s NCT07685600 study, officially titled “An Open-label, Randomised, Two Arm, Fixed Sequence Study in Healthy Participants to
GSIE ETF FAQ
What was GSIE’s price range in the past 12 months?
What is the AUM of GSIE?
Is GSIE overvalued?
Does GSIE pay dividends?
How many shares outstanding does GSIE have?
Which hedge fund is a major shareholder of GSIE?
Top 10 Holdings
| Name | Weight % |
|---|---|
| ASMLASML Holding NV | 1.99% |
| RYRoyal Bank Of Canada | 1.16% |
| ROPRoche Holding | 1.15% |
| NOVNNovartis | 1.08% |
| HSBAHsbc Holdings Plc (UK) | 1.01% |
| 6857Advantest Corp | 0.96% |
| TDToronto Dominion Bank | 0.87% |
| AZNAstraZeneca plc | 0.86% |
| 6098Recruit Holdings Co | 0.78% |
| SHELShell plc (UK) | 0.76% |
| Total | 10.62% |







